Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 351
Filtrar
Más filtros

Intervalo de año de publicación
1.
J Infect Dis ; 226(5): 907-919, 2022 09 13.
Artículo en Inglés | MEDLINE | ID: mdl-35263421

RESUMEN

BACKGROUND: The ECHO trial randomized women to intramuscular depot medroxyprogesterone acetate (DMPA-IM), levonorgestrel implant (LNG-implant), or copper intrauterine device (Cu-IUD). In a substudy of the ECHO trial, we tested the hypothesis that contraceptives influence genital inflammation by comparing cervicovaginal cytokine changes following contraception initiation. In addition, we compared cytokine profiles in women who acquired HIV (cases) versus those remaining HIV negative (controls). METHODS: Women (n = 251) from South Africa and Kenya were included. Twenty-seven cervicovaginal cytokines were measured by Luminex at baseline, and 1 and 6 months after contraceptive iTanko et alnitiation. In addition, cytokines were measured preseroconversion in HIV cases (n = 25) and controls (n = 100). RESULTS: At 6 months after contraceptive initiation, women using Cu-IUD had increased concentrations of 25/27 cytokines compared to their respective baseline concentrations. In contrast, women initiating DMPA-IM and LNG-implant did not experience changes in cervicovaginal cytokines. Preseroconversion concentrations of IL-1ß, IL-6, and TNF-α, previously associated with HIV risk, correlated with increased HIV risk in a logistic regression analysis, although not significantly after correcting for multiple comparisons. Adjusting for contraceptive arm did not alter these results. CONCLUSIONS: Although Cu-IUD use broadly increased cervicovaginal cytokine concentrations at 6 months postinsertion, these inflammatory changes were found not to be a significant driver of HIV risk. CLINICAL TRIALS REGISTRATION: NCT02550067.


Asunto(s)
Anticonceptivos Femeninos , Genitales , Femenino , Humanos , Anticoncepción/métodos , Anticonceptivos Femeninos/efectos adversos , Citocinas , Genitales/efectos de los fármacos , Genitales/patología , Infecciones por VIH/tratamiento farmacológico , Dispositivos Intrauterinos de Cobre/efectos adversos , Levonorgestrel/efectos adversos , Acetato de Medroxiprogesterona/efectos adversos
2.
Ann Pharmacother ; 55(4): 543-548, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-32808541

RESUMEN

OBJECTIVE: To review the incidence, risk factors, prevention, and management of genital mycotic infections (GMIs) associated with sodium-glucose cotransporter 2 (SGLT2) inhibitors. DATA SOURCES: A literature search of PubMed and Reactions Weekly was performed in February 2020 with updated searches monthly through July 2020 to identify relevant data regarding SGLT2 inhibitors and GMIs. Manufacturers of each agent were contacted, and clinical practice guidelines were consulted. STUDY SELECTION AND DATA EXTRACTION: All available literature was evaluated for inclusion based on relevance to the research question, timeliness of the publication, validity, and impact on current practice. A date limit was not set; however, publications from 2010 to July 2020 were prioritized. DATA SYNTHESIS: The 3- to 4-fold increased incidence of GMIs is considered a classwide effect of SGLT2 inhibitors. Female sex and a prior history of GMIs are factors associated with the highest risk, whereas circumcised males are at the lowest risk of SGLT2 inhibitor-induced GMI. Personal hygiene advice can reduce the infection risk. When candidiasis occurs, it is often mild and responsive to treatment and often does not require discontinuation of the medication. RELEVANCE TO PATIENT CARE AND CLINICAL PRACTICE: This narrative review can assist in shared decision-making discussions with patients who may benefit from SGLT2 inhibitors and provides guidance for health care professionals managing SGLT2 inhibitor-associated GMIs. CONCLUSIONS: SGLT2 inhibitors predispose patients to developing mild GMIs. Strong consideration should be given to avoid SGLT2 inhibitors in female patients with a history of severe, recurrent infections. Preventive strategies are optimized diabetes management and personal hygiene advice.


Asunto(s)
Candidiasis Vulvovaginal/inducido químicamente , Candidiasis Vulvovaginal/prevención & control , Manejo de la Enfermedad , Genitales/efectos de los fármacos , Higiene , Inhibidores del Cotransportador de Sodio-Glucosa 2/efectos adversos , Canagliflozina/efectos adversos , Canagliflozina/uso terapéutico , Candidiasis Vulvovaginal/epidemiología , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/epidemiología , Femenino , Genitales/microbiología , Humanos , Hipoglucemiantes/efectos adversos , Hipoglucemiantes/uso terapéutico , Masculino , Transportador 2 de Sodio-Glucosa/metabolismo , Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico
3.
Regul Toxicol Pharmacol ; 122: 104897, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33639256

RESUMEN

Benzoic acid (BA) was administered in the diet to male and female Sprague Dawley Crl:CD(SD) rats in an OECD Test Guideline 443 Extended One-Generation Reproductive Toxicity (EOGRT) study to test for effects that may occur as a result of pre- and postnatal exposure. The study included cohorts of F1 offspring to evaluate potential effects of benzoic acid on reproduction, the developing immune system, and the developing neurological system with the inclusion of learning and memory assessments. Benzoic acid was incorporated in the diet at concentrations of 0, 7,500, 11,500, and 15,000 mg/kg diet (ppm). These concentrations were selected based on the results of preliminary studies, and, based on average food consumption, were intended to supply BA doses of approximately 0, 500, 750, and 1000 mg/kg bw/day. To avoid exceeding these target dose levels, the dietary concentrations were adjusted (based on historical control body weight and food consumption data) to maintain the target mg/kg bw/day dose levels during those life periods when food intake per unit of body weight was increased to support milk production by females (gestation and lactation) and rapid pup growth (post-weaning). In the parental (F0) generation, survival, clinical observations, organ weights, pathology, hematology, serum chemistry, urinalysis, and bile acids were unaffected by BA administration. Reproductive parameters were also unaffected by BA administration. In the F1 generation, survival, growth and developmental landmarks, organ weights, pathology, immunotoxicity assessment, and neurotoxicity and neurobehavioral parameters such as auditory startle response, locomotor activity, learning and memory assessments were unaffected by BA administration, as were clinical pathology (hematology, serum chemistry, urinalysis, bile acids and thyroid hormones) and reproductive performance. Similarly, no adverse effects or systemic toxicity were observed in the F2 generation. Overall, the highest dietary concentration (15,000 ppm), providing a dosage of approximately 1000 mg/kg bw/day, was the NOAEL for benzoic acid in this EOGRT study.


Asunto(s)
Ácido Benzoico/farmacología , Conservantes de Alimentos/farmacología , Genitales/efectos de los fármacos , Animales , Peso Corporal , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Nivel sin Efectos Adversos Observados , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley
4.
Regul Toxicol Pharmacol ; 122: 104914, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33684452

RESUMEN

Ethyl(dimethyl)(tetradecyl)ammonium ethyl sulfate, used in laundry detergents, shampoos, and body soaps, is classified by the Japanese Chemical Substances Control Law as a priority assessment chemical substance for environmental effects. However, its toxicity data for human health are insufficient. This study evaluated this chemical under the Safety Examination of Existing Chemicals and Safety Programmes of the Ministry of Health, Labour and Welfare (MHLW). The MHLW conducted bacterial reverse mutation (Ames test), in vitro chromosomal aberration, and combined repeated-dose and reproductive/developmental toxicity screening tests. We performed a screening assessment of ethyl(dimethyl)(tetradecyl)ammonium ethyl sulfate for human health. The chemical showed a negative reaction in the Ames test and a positive reaction in the in vitro chromosomal aberration test with metabolic activation in rats. The combined repeated-dose and reproductive/developmental toxicity screening test showed significantly decreased food consumption at 50 mg/kg body weight/day, but no reproductive and developmental toxicity was observed. The no-observed-effect level of 15 mg/kg/day was obtained as a screening value. Therefore, this chemical was classified as hazard class 3, with a derived-no-effect level of 0.025 mg/kg/day. The results of this study will be useful for risk assessment of groups of structurally similar alkyl quaternary ammonium surfactants.


Asunto(s)
Genitales/efectos de los fármacos , Compuestos de Amonio Cuaternario/toxicidad , Animales , Línea Celular , Cricetinae , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos , Femenino , Masculino , Pruebas de Mutagenicidad , Nivel sin Efectos Adversos Observados , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley
5.
Regul Toxicol Pharmacol ; 120: 104840, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33321148

RESUMEN

In 2017, JECFA requested reproductive and developmental toxicity studies to finalize an acceptable daily intake for solvent rosemary extracts. Thus, an OECD 421 reproductive/developmental toxicity study was conducted using an acetone rosemary extract that complied with JECFA and EFSA food additive specifications. Rosemary extract was provided to rats at dietary concentrations of 0 (control), 2100, 3600, or 5000 mg/kg, for 14 days before mating, during mating, and thereafter (throughout gestation and up to Lactation Day 13 for females) until necropsy. General toxicity (clinical signs, body weight, food consumption) and reproductive/developmental outcomes (fertility and mating performance, estrous cycles, anogenital distance, thyroid hormones, reproductive organ weights, thyroid histopathology) were assessed. There were no signs of general toxicity and no effects on reproduction; thus, the highest concentration tested (equivalent to mean daily intakes of 316 or 401 mg/kg bw/day [149 or 189 mg/kg bw/day carnosol and carnosic acid] for males and females, respectively) was established as the no-observed-adverse-effect level for general and reproductive toxicity. Dose-related reductions in T4 were observed for Day 13 pups (not seen on Day 4) but were not accompanied by thyroid weight changes or histopathological findings; further investigations are required to determine the biological relevance of these T4 reductions.


Asunto(s)
Acetona/toxicidad , Genitales/efectos de los fármacos , Extractos Vegetales/toxicidad , Reproducción/efectos de los fármacos , Rosmarinus , Animales , Animales Recién Nacidos , Discapacidades del Desarrollo/inducido químicamente , Discapacidades del Desarrollo/patología , Evaluación Preclínica de Medicamentos/métodos , Femenino , Genitales/fisiología , Masculino , Nivel sin Efectos Adversos Observados , Tamaño de los Órganos , Extractos Vegetales/aislamiento & purificación , Embarazo , Ratas , Reproducción/fisiología
6.
Biol Reprod ; 103(2): 318-322, 2020 08 04.
Artículo en Inglés | MEDLINE | ID: mdl-32561906

RESUMEN

Contributions from a diverse set of scientific disciplines will be needed to help individuals make fully informed decisions regarding contraceptive choices least likely to promote HIV susceptibility. This commentary recaps contrasting interpretations of results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial, a study that compared HIV risk in women using the progestin-only injectable contraceptive depot medroxyprogesterone acetate (DMPA) vs. two other contraceptive choices. It also summarizes results from basic and translational research that establish biological plausibility for earlier clinical studies that identified enhanced HIV susceptibility in women using DMPA.


Asunto(s)
Anticoncepción/métodos , Anticonceptivos Femeninos/administración & dosificación , Genitales/efectos de los fármacos , Infecciones por VIH/etiología , Acetato de Medroxiprogesterona/administración & dosificación , Adulto , Epitelio/efectos de los fármacos , Femenino , Humanos
7.
Biol Reprod ; 102(2): 276-291, 2020 02 14.
Artículo en Inglés | MEDLINE | ID: mdl-31621835

RESUMEN

Anti-androgenic endocrine-disrupting chemicals (EDCs) can cross the placenta to modify early offspring sexual dimorphic markers. These changes are linked to anogenital distance (AGD), which is an androgen-sensitive anthropometric parameter used as a biomarker of perineal growth and caudal migration of the genital tubercle. This review aimed to summarize strength of evidence for associations of in utero exposure to EDCs with AGD and to identify gaps and limitations in the literature so as to inform future research. We performed an electronic search of English literature in September 2019 in medical literature analysis and retrieval system online (MEDLINE), Web of Science and Toxline. We included epidemiological studies that examined in utero exposure to persistent and nonpersistent EDCs and considered AGD in offspring as an outcome. Our review contained 16 investigations examining exposure to persistent EDCs (nine studies) and nonpersistent EDCs (seven studies). Some individual studies reported an inverse association between exposure to bisphenol A (BPA), dioxins, perfluoroalkyl substances, and organochlorides and AGD in both male and female offspring. Meta-analysis of three studies found a small reduction of AGD in female offspring exposed to BPA. The number of studies per chemical is small, and number of subjects examined is limited; so, replication of these results is needed. To achieve more specificity and better replication of results, future studies should establish the association of nonpersistent EDCs using multiple urine samples, evaluate the cumulative impact of exposure to a mixture of anti-androgenic chemicals, and offer adequate consideration of more maternal- and children-related confounding factors.


Asunto(s)
Canal Anal/anatomía & histología , Disruptores Endocrinos/administración & dosificación , Genitales/anatomía & histología , Exposición Materna/efectos adversos , Efectos Tardíos de la Exposición Prenatal , Canal Anal/efectos de los fármacos , Antropometría , Femenino , Genitales/efectos de los fármacos , Humanos , Masculino , Embarazo
8.
J Appl Toxicol ; 40(10): 1396-1409, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32418265

RESUMEN

Polychlorinated biphenyls (PCBs) are a class of persistent organic environmental pollutants with a total of 209 homologs. The homolog 2,3',4,4',5-pentachlorobiphenyl (PCB118) is one of the most important dioxin-like PCBs and is highly toxic. PCB118 can accumulate in human tissues, serum and breast milk, which leads to direct exposure of the fetus during development. In the present study, pregnant mice were exposed to 0, 20 and 100 µg/kg/day of PCB118 during the stage of fetal primordial germ cell migration. Compared with the control group, we found morphological alterations of the seminiferous tubules and a higher sperm deformity rate in the male offspring in the treatment groups. Furthermore, the methylation patterns in the treatment groups of the imprinted genes H19 and Gtl2 in the sperm were altered in the male offspring. We also characterized the disturbance of the expression levels of DNA methyltransferase 1 (Dnmt1), Dnmt3a, Dnmt3b, Dnmt3l, and Uhrf1. The results indicated that intrauterine exposure to low doses of PCB118 could significantly damage the reproductive health of the male offspring. Therefore, attention should be paid to the adverse effects of PCB118 exposure during pregnancy on the reproductive system of male offspring.


Asunto(s)
Contaminantes Ambientales/toxicidad , Epigénesis Genética/efectos de los fármacos , Genitales/efectos de los fármacos , Bifenilos Policlorados/toxicidad , Efectos Tardíos de la Exposición Prenatal , Espermatozoides/efectos de los fármacos , Útero/efectos de los fármacos , Animales , Femenino , Masculino , Exposición Materna/efectos adversos , Ratones , Modelos Animales , Embarazo
9.
Ecotoxicol Environ Saf ; 204: 111109, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32798751

RESUMEN

Microplastic (MP) pollution of the marine environment is now a growing global concern posing a threat to a variety of species through the ingestion and transfer within food webs. This is considered a potential toxicological threat to marine species due to the chemical additives used to make many plastic products, or the persistent organic pollutants that may accumulate on them while residing in the environment. While the presence of MPs in the marine environment is widely documented, there are no other review articles providing a summary of published effect studies of MPs on the immune and reproductive systems of marine species. This manuscript reviews reproductive and immune-system changes in response to MPs in 7 and 9 species, respectively. Some species such as Mytilus galloprovincialis and oyster Crassostrea gigas were investigated in multiple papers. Most studies have been conducted on invertebrates, and only 3 studies have been performed on vertebrates, with exposure times ranging between 30 min and 60 days. A review of the literature revealed that the most common MPs types studied in relation to adverse impacts on immune system and reproductive success in marine species were polystyrene (PS) and polyethylene (PE). The immune system's responses to MPs exposure varied depending on the species, with altered organismal defense mechanisms and neutrophil function observed in fish and changes in lysosomal membrane stability and apoptotic-like nuclear alterations in phagocytes reported in invertebrate species. Reproductive responses to MPs exposure, varied depending on species, but included significant reduction in gamete and oocyte quality, fecundity, sperm swimming speed, and quality of offspring. The lack of published data means that developing a clear understanding of the impact across taxonomic groups with different feeding and behavioral traits is often difficult. Further work is required to better understand the risk MPs pose to the immune and reproductive systems of marine species in order to fully evaluate the impact these ubiquitous pollutants are having on marine ecosystems and the associated goods and services they provide.


Asunto(s)
Genitales/efectos de los fármacos , Sistema Inmunológico/efectos de los fármacos , Microplásticos/toxicidad , Contaminantes Químicos del Agua/toxicidad , Animales , Crassostrea , Ecosistema , Monitoreo del Ambiente , Contaminantes Ambientales/farmacología , Contaminación Ambiental , Peces , Cadena Alimentaria , Genitales/química , Invertebrados , Microplásticos/análisis , Mytilus/efectos de los fármacos , Plásticos , Polietileno , Poliestirenos , Contaminantes Químicos del Agua/análisis
10.
Chin J Physiol ; 63(5): 235-243, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33109790

RESUMEN

Although selenium is known to be essential for reproductive function, studies have indicated the adverse effect with its prolonged use. The present study investigated the duration-related effect of selenium administrations on reproductive hormones and estrous cycle indices in adult female Wistar rats exposed to a model of light pollution using altered photoperiod (AP). Ninety-six cyclic female Wistar rats displaying 4-5 days' estrous cycle length (ECL) and weighing 148-152 g were randomly divided into short and long experimental cohorts consisting of six groups each and spanning for 1 and 8 weeks, respectively. Each consisted of control, high selenium dose (HSE), low selenium dose (LSE), AP, AP + HSE, and AP + LSE. The rats were orally administered high dose (150 µg/kg) and low dose (100 µg/kg) of sodium selenite once per day. The estrous cycle indices were monitored. Plasma levels of follicle-stimulating hormone, luteinizing hormone (LH), estradiol (E), progesterone (P), prolactin, E/P ratio, and histology of ovary and uterine horn were evaluated. The statistical analysis was performed using Statistical Package for the Social Sciences. In AP rats, HSE and LSE caused no significant effect on LH, E, P, and E/P ratio, ECL, estrus interval (EI), and estrous cycle ratio (ECR). The effect of HSE and LSE on LH, E, P, E/P ratio, and ECL showed no duration-dependent increase, but there was a duration-dependent increase in EI and ECR at low dose. The study indicated that administration of HSE of selenium improved reproductive function in photo-pollution-exposed rats irrespective of the duration of treatment.


Asunto(s)
Genitales/efectos de los fármacos , Genitales/efectos de la radiación , Homeostasis/efectos de los fármacos , Fotoperiodo , Selenio/administración & dosificación , Animales , Estradiol , Femenino , Hormona Folículo Estimulante , Genitales/fisiopatología , Hormona Luteinizante , Ratas , Ratas Wistar
11.
Int J Mol Sci ; 21(6)2020 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-32178293

RESUMEN

Anthropogenic contaminants in water can impose risks to reproductive health. Most of these compounds are known to be endocrine disrupting chemicals (EDCs). EDCs can impact the endocrine system and subsequently impair the development and fertility of non-human animals and humans. The source of chemical contamination in water is diverse, originating from byproducts formed during water disinfection processes, release from industry and livestock activity, or therapeutic drugs released into sewage. This review discusses the occurrence of EDCs in water such as disinfection byproducts, fluorinated compounds, bisphenol A, phthalates, pesticides, and estrogens, and it outlines their adverse reproductive effects in non-human animals and humans.


Asunto(s)
Disruptores Endocrinos/efectos adversos , Sistema Endocrino/efectos de los fármacos , Genitales/efectos de los fármacos , Reproducción/efectos de los fármacos , Agua/química , Animales , Contaminantes Ambientales/efectos adversos , Humanos , Contaminantes Químicos del Agua/efectos adversos
12.
Exp Parasitol ; 203: 30-35, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31150655

RESUMEN

Schistosoma mansoni adult worms are extensively challenged by reactive oxygen species from intrinsic sources. However, the effects of extrinsic sources such as ethanol have not been looked at in schistosomes. We examined adult worms recovered from ethanol-consuming mice by light (LM), confocal (CM) and scanning electron microscopy (SEM) to address this question. Schistosomiasis-infected mice were orally gavaged with 18% (v/v) ethanol from 35 to 63 days post-infection, when they were euthanized. CM examination revealed reduced germ cells density (-36%, p = 0.0001) and sperm density (-58%, p = 0.0001) in testicular lobes, and immature cells in seminal vesicle compared to unexposed control worms. Female worms showed reduced density of vitellin glands (-71%, p = 0.0001), maturation of oocytes (-7%, p = 0.0071) and reduced spermatozoa density (-23%, p = 0.0002) within the seminal receptacle. SEM revealed remarkable damages in male's tegument, including tubercles flattening, tegumental peeling and erosive lesions. Given that lipids are present in reproductive system and tegument, our results suggest that phenotypic changes are due to ethanol-induced lipid peroxidation. To the best of our knowledge, this is the first report revealing the biological action of ethanol intake on adult schistosomes in vivo.


Asunto(s)
Etanol/administración & dosificación , Schistosoma mansoni/efectos de los fármacos , Esquistosomiasis mansoni/parasitología , Administración Oral , Animales , Etanol/toxicidad , Femenino , Genitales/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Masculino , Venas Mesentéricas/parasitología , Ratones , Microscopía Confocal , Microscopía Electrónica de Rastreo , Estrés Oxidativo/efectos de los fármacos , Fenotipo , Sistema Porta/parasitología , Reproducción/efectos de los fármacos , Schistosoma mansoni/fisiología , Schistosoma mansoni/ultraestructura
13.
Regul Toxicol Pharmacol ; 108: 104472, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31494191

RESUMEN

The OECD guideline 407 outlines the conduct of 28-day studies in rodents to detect systemic toxicity with focus on endocrine and immunotoxic effects. It was validated with the rat as preferred model species. Justification is required for other rodent species, as an increased variability is expected compared to the rat. We investigated the variability of organ weights in the mouse and compared this to data published for the rat in the validation report of test guideline 407. Furthermore, the influence of the immunotoxic model substance cyclophosphamide on spleen and thymus weights in the mouse in immunotoxicity studies (duration 28 days) is reported and discussed, an immunotoxic model substance was not included in the validation report. Historical control data were compiled for mouse studies performed according to OECD 407 and for immunotoxicity studies between 2008 and 2013 at BASF SE. For absolute weights, the coefficient of variation was determined for each study group and compared with the rat. Adrenal glands, ovaries and to lesser degree testes and prostate showed higher coefficients of variation in the mouse (most pronounced in adrenal glands in male animals: rat 5%-17%, CD1 mouse 20%-51%). Effects of cyclophosphamide were best detected measuring the thymus weight.


Asunto(s)
Variación Biológica Individual , Peso Corporal , Grupos Control , Tamaño de los Órganos , Pruebas de Toxicidad Subaguda , Glándulas Suprarrenales/anatomía & histología , Glándulas Suprarrenales/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Encéfalo/anatomía & histología , Encéfalo/efectos de los fármacos , Ciclofosfamida/toxicidad , Femenino , Genitales/anatomía & histología , Genitales/efectos de los fármacos , Corazón/anatomía & histología , Corazón/efectos de los fármacos , Inmunosupresores/toxicidad , Riñón/anatomía & histología , Riñón/efectos de los fármacos , Hígado/anatomía & histología , Hígado/efectos de los fármacos , Masculino , Ratones Endogámicos C57BL , Tamaño de los Órganos/efectos de los fármacos , Ratas , Especificidad de la Especie , Bazo/anatomía & histología , Bazo/efectos de los fármacos , Timo/anatomía & histología , Timo/efectos de los fármacos
14.
Toxicol Ind Health ; 35(6): 403-409, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31131740

RESUMEN

The technologically interesting properties of palladium nanoparticles (Pd-NPs) allowed their widespread industrial application, although concerns emerged on increasing general and occupational levels of exposure. In this context, to assess the toxicological behavior of Pd-NPs, and particularly their endocrine disruptive potential, has become a public health priority. Therefore, we evaluated Pd-NP impact on the female endocrine reproductive system of Wistar rats sub-chronically treated for 90 days with increasing doses of this xenobiotic (0.12, 1.2, and 12 µg/kg, administered at days 1, 30, and 60 for cumulative doses of 0.36, 3.6, and 36 µg/kg) via the intravenous route. In this regard, we investigated potential alterations in different sex hormone, for example, estradiol, follicle-stimulating hormone (FSH), luteinizing hormone, progesterone, and testosterone, serum concentrations. All treated groups showed significantly greater levels of FSH compared to controls, suggesting a possible impact of Pd-NPs on the regulatory system that controls the normal physiology of female reproductive function. Although relevant, since obtained under sub-chronic, low-dose conditions of exposure resembling those encountered in real-world scenarios, the present results are preliminary and require confirmation as well as identification of the possible underlining molecular mechanisms. From a public and occupational health perspective, implications for the reproductive health of exposed subjects and the next generations of women exposed during their childbearing age or pregnancy should be elucidated. This information is essential to elaborate adequate preventive strategies for assessing and controlling possible Pd-NPs adverse effects on the endocrine system.


Asunto(s)
Hormona Folículo Estimulante/sangre , Genitales/efectos de los fármacos , Hormona Luteinizante/sangre , Nanopartículas del Metal/análisis , Paladio/sangre , Animales , Disruptores Endocrinos/farmacología , Femenino , Sistema Hipotálamo-Hipofisario , Nanopartículas del Metal/toxicidad , Paladio/toxicidad , Datos Preliminares , Distribución Aleatoria , Ratas , Ratas Wistar
15.
Zhongguo Zhong Yao Za Zhi ; 44(16): 3406-3414, 2019 Aug.
Artículo en Zh | MEDLINE | ID: mdl-31602902

RESUMEN

This paper summarizes the research progress of reproductive toxicity of Tripterygium wilfordii from 1979,and the toxicity characterization,damage mechanism,and attenuated measures are summarized. It was found that,the reproductive toxicity caused by T. wilfordii is mainly distributed on components of Tripterygium glycosides,triptolide,tripchlorolide,and clinically preparations,such as Leigongteng Tablets and Tripterygium Glycosides Tablets. Adverse reactions to male reproductive system caused by Tripterygium preparations mainly include decreased sperm motility,oligospermia or spermatozoa,decreased fertility or infertility,etc. Long-term drug use may also lead to testicular atrophy and decreased sexual desire. Adverse reactions to women are mainly manifested as menstrual disorders,decreased menstrual volume or even amenorrhea,decreased sexual desire,infertility,etc. The reproductive toxicity of T. wilfordii is related to apoptosis of reproductive cells,disturbance of spermatogenesis or oogenesis,damage of testis and ovary in reproductive target tissues,and changes of internal environment in gonad tissues( hormones,hormone synthesis rate-limiting enzymes and energy metabolism). Drug compatibility,hormone replacement,medication duration and dosage form changes can help reduce the damage of T. wilfordii to the reproductive system. In addition,in view of the existing problems in the current study,the author proposes new directions in clinical studies,pharmacological metabolism mechanism,preparation quality standards and new therapeutic effects,etc.,to provide a basis for the safe and reasonable clinical application of T. wilfordii.


Asunto(s)
Medicamentos Herbarios Chinos/toxicidad , Genitales/efectos de los fármacos , Tripterygium/toxicidad , Femenino , Humanos , Masculino , Ovario/efectos de los fármacos , Testículo/efectos de los fármacos
16.
Biol Reprod ; 99(6): 1184-1193, 2018 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-29931162

RESUMEN

Exposure to estrogenic endocrine disrupting chemicals (EDCs) during in utero development has been linked to the increasing incidence of disorders of sexual development. Hypospadias, the ectopic placement of the urethra on the ventral aspect of the penis, is one of the most common DSDs affecting men, and can also affect women by resulting in the misplacement of the urethra. This study aimed to comprehensively assess the resulting hypospadias phenotypes in male and female mice exposed in utero from embryonic day 9.5 to 19.5 to the potent estrogenic endocrine disruptor, diethylstilbestrol, at a high, clinically relevant dose, and a low, previously untested dose, administered via water. The anogenital distance of male pups was significantly reduced and hypospadias was observed in males at a high frequency. Females exhibited hypospadias and urethral-vaginal fistula. These results demonstrate the ability of an estrogen receptor agonist to disrupt sexual development in both male and female mice, even at a low dose, administered via drinking water.


Asunto(s)
Anomalías Inducidas por Medicamentos , Dietilestilbestrol/toxicidad , Embrión de Mamíferos/efectos de los fármacos , Genitales/efectos de los fármacos , Genitales/embriología , Animales , Dietilestilbestrol/administración & dosificación , Relación Dosis-Respuesta a Droga , Agua Potable , Estrógenos no Esteroides/administración & dosificación , Estrógenos no Esteroides/toxicidad , Femenino , Masculino , Exposición Materna , Ratones , Ratones Endogámicos C57BL , Embarazo
17.
Reprod Biomed Online ; 37(6): 732-740, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30539738

RESUMEN

RESEARCH QUESTION: What is the association between prenatal exposure to persistent organic pollutants, separately and combined, and anogenital distance (in-utero endocrine disruption marker). DESIGN: A cohort study conducted in Sonora, Mexico. Blood concentrations of polychlorobiphenyls (PCB) 28, 74, 118, 138/158, 153, 170, 180 and the isomers of dichlorodiphenyltrichloroethane (DDT) and its metabolites were determined in women in the third trimester of pregnancy; three variants of anogenital distance were measured on five occasions during the first year of life of their infants: 82 girls (402 observations) and 74 boys (356 observations). RESULTS: Boys had negative and significant associations between anogenital distance/height and the concentrations of PCB 28 (beta = - 0.005;P = 0.006), PCB 74 (beta = - 0.003;P = 0.013), and PCB 170 (beta = - 0.005;P = 0.001) when analysed individually. Negative and significant associations were also found using statistical models applied to mixtures of compounds. The latter associations were sometimes larger in magnitude and significance, suggesting a possible potentiation of the compounds. No associations were observed between anogenital distance and DDT in either sex or with PCB in girls. CONCLUSIONS: The decreased anogenital distance associated with prenatal exposure to the persistent organic pollutants, observed consistently in different analyses, suggests an under-masculinizing effect of these environmental pollutants in boys.


Asunto(s)
DDT/toxicidad , Contaminantes Ambientales/toxicidad , Desarrollo Fetal/efectos de los fármacos , Bifenilos Policlorados/toxicidad , Efectos Tardíos de la Exposición Prenatal , Canal Anal/anatomía & histología , Canal Anal/efectos de los fármacos , Canal Anal/embriología , Antropometría , Estudios de Cohortes , DDT/sangre , Contaminantes Ambientales/sangre , Femenino , Genitales/anatomía & histología , Genitales/efectos de los fármacos , Genitales/embriología , Humanos , Masculino , México , Bifenilos Policlorados/sangre , Embarazo , Tercer Trimestre del Embarazo
18.
Regul Toxicol Pharmacol ; 92: 370-381, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29248488

RESUMEN

There are conflicting literature reports that parabens, useful antimicrobial additives in pharmaceuticals, may have estrogenic activity. We conducted a comprehensive study to determine whether propylparaben (PP) administration to juvenile rats is associated with adverse effects on reproductive development and function. PP was administered orally once daily to groups of Crl:CD(SD) rats at doses of 0 (vehicle), 10, 100, or 1,000 mg/kg on Postnatal Days (PNDs) 4-90. In-life observations, clinical pathology, reproductive organ weights and histopathology, landmarks of sexual maturation, estrous cyclicity and functional reproductive competence were assessed. A conventional uterotrophic assay was conducted separately using the same doses. Systemic exposures to PP and 3 metabolites were evaluated on PND 7, 21 and 83. These studies demonstrated that PP was well tolerated when administered from PND 4-90 at all doses (AUC[0-T] on PND 83 = 69.9 ng•h/mL). Para-hydroxybenzoic acid, a non-estrogenic compound, was the predominant metabolite contributing to 95% of the total exposure at 1,000 mg/kg/day on PND 7. There was no evidence of estrogenic activity at any dose, and no effects on reproductive organs or function. The No-Observed-Adverse-Effect-Level (NOAEL) was 1,000 mg/kg/day.


Asunto(s)
Genitales/efectos de los fármacos , Parabenos/efectos adversos , Reproducción/efectos de los fármacos , Animales , Ciclo Estral/efectos de los fármacos , Femenino , Masculino , Nivel sin Efectos Adversos Observados , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Maduración Sexual/efectos de los fármacos
19.
J Appl Toxicol ; 38(1): 51-80, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28608465

RESUMEN

As bisphenol A (BPA) is characterized by a pronounced influence on human hormonal regulation, particular attention has been aimed at understanding its role in reproductive processes in males and females, as well as on fetal development. Owing to the increasing number of alarming reports on the negative consequences of the presence of BPA in human surroundings, more and more studies are being undertaken to clarify the negative effects of BPA on human reproductive processes. The aim of this work was to collect and summarize data on the influence of BPA exposure on reproductive health. Based on an analysis of selected publications it was stated that there is strong proof confirming that BPA is an ovarian, uterine and prostate toxicant at a level below the lowest observed adverse effect level (50 mg kg-1 bodyweight) as well as a level below the proposed safe level (4 µg kg-1 bodyweight). It seems there is also reliable evidence in relation to the negative effect of BPA on sperm quality and motility. Limited evidence also pertains to the case of the potential of BPA to affect polycystic ovary syndrome occurrence. Although in epidemiological studies this disease was common, in studies on animal models such results were still not confirmed. No unambiguous results of epidemiological studies and with animal models were obtained in relation to the evaluation of associations between BPA and implantation failure in women, evaluation of associations between BPA and sexual dysfunction in men, and impact of BPA on birth rate, birth weight and length of gestation. Copyright © 2017 John Wiley & Sons, Ltd.


Asunto(s)
Compuestos de Bencidrilo/toxicidad , Exposición a Riesgos Ambientales/efectos adversos , Contaminantes Ambientales/toxicidad , Infertilidad , Fenoles/toxicidad , Reproducción/efectos de los fármacos , Animales , Compuestos de Bencidrilo/farmacocinética , Línea Celular , Proliferación Celular/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Exposición a Riesgos Ambientales/análisis , Contaminantes Ambientales/farmacocinética , Femenino , Fertilización In Vitro/efectos de los fármacos , Genitales/efectos de los fármacos , Genitales/patología , Humanos , Infertilidad/inducido químicamente , Infertilidad/epidemiología , Masculino , Fenoles/farmacocinética
20.
Toxicol Ind Health ; 34(3): 200-210, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29506458

RESUMEN

Carbon nanotubes (CNTs) are widely used in the aerospace, automotive, and electronics industries because of their stability, enhanced metallic, and electrical properties. CNTs are also being investigated for biomedical applications such as drug delivery systems and biosensors. However, the toxic potential of CNTs was reported in various cell lines and animal models. The toxicity depends on diverse properties of the CNTs, such as length, aspect ratio, surface area, degree of aggregation, purity, concentration, and dose. In addition, CNTs and/or associated contaminants were well known for oxidative stress, inflammation, apoptosis, pulmonary inflammation, fibrosis, and granuloma in lungs. The increased production of CNTs likely enhanced the possibility of its exposure in people. Studies on the toxicity of CNTs are mainly focused on the pulmonary effects after intratracheal administration, and only a few studies are reported about the toxicity of CNTs via other routes of exposure. So, it is essential to consider the chronic toxicity of CNTs before using them for various biomedical applications. This review focuses on the potential toxicities of CNTs.


Asunto(s)
Pulmón/efectos de los fármacos , Nanotubos de Carbono/efectos adversos , Animales , Sistema Cardiovascular/efectos de los fármacos , Genitales/efectos de los fármacos , Humanos , Inflamación/inducido químicamente , Lesión Pulmonar/inducido químicamente , Ratones , Modelos Animales , Estrés Oxidativo/efectos de los fármacos , Ratas , Tensoactivos/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA